谷氨酰胺
肿瘤微环境
癌细胞
免疫系统
葡萄糖摄取
生物
mTORC1型
细胞生物学
细胞
新陈代谢
碳水化合物代谢
癌症研究
癌症
生物化学
化学
免疫学
信号转导
内分泌学
氨基酸
PI3K/AKT/mTOR通路
遗传学
胰岛素
作者
Bradley I. Reinfeld,MZ Madden,M. Wolf,Anna Chytil,JE Bader,Andrew R. Patterson,AS Cohen,Alaa Kassim Ali,T. Brian,Alexander Muir,CA Lewis,RA Hongo,KL Young,Rachel E. Brown,Vera M. Todd,Tessa Huffstater,Abin Abraham,RT O’Neil,MH Wilson,Feng Xin
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2020-08-10
被引量:31
标识
DOI:10.1101/2020.08.10.238428
摘要
The tumor microenvironment (TME) includes transformed cancer and infiltrating immune cells 1,2 . Cancer cells can consume large quantities of glucose through Warburg metabolism 3,4 that can be visualized with positron emission tomography (PET). While infiltrating immune cells also rely on glucose, disruptions to metabolism can contribute to tumor immunological evasion 5–9 . How immune cell metabolism is programmed or restrained by competition with cancer cells for nutrients, remains uncertain. Here we used PET tracers to measure the accessibility of glucose and glutamine to cell subsets in the TME. Surprisingly, myeloid cells including macrophages were the greatest consumers of intra-tumoral glucose, followed by T cells and cancer cells. Cancer cells, in contrast, had the highest glutamine uptake. This distinct nutrient partitioning was programmed through selective mTORC1 signaling and glucose or glutamine-related gene expression. Inhibition of glutamine uptake enhanced glucose uptake across tumor resident cell types and shifted macrophage phenotype, demonstrating glucose is not limiting in the TME. Thus, cancer cells are not the only cells in tumors which exhibit high glucose uptake in vivo and instead preferentially utilize glutamine over other cell types. We observe that intrinsic cellular programs can play a major role in the use of some nutrients. Together, these data argue cell selective partitioning of glucose and glutamine can be exploited to develop therapies and imaging strategies to alter the metabolic programs of specific cell populations in the TME.
科研通智能强力驱动
Strongly Powered by AbleSci AI